statistiche ricercatore

Continente	#
AS - Asia	493
NA - Nord America	329
EU - Europa	213
Continente sconosciuto - Info sul continente non disponibili	26
SA - Sud America	24
AF - Africa	15
OC - Oceania	1
Totale	1.101

Nazione	#
US - Stati Uniti d'America	311
CN - Cina	139
SG - Singapore	118
VN - Vietnam	116
IT - Italia	104
KR - Corea	43
NL - Olanda	24
HK - Hong Kong	21
BR - Brasile	18
DE - Germania	18
SE - Svezia	17
IN - India	14
BD - Bangladesh	13
FR - Francia	13
JP - Giappone	8
CA - Canada	7
GB - Regno Unito	7
FI - Finlandia	6
IE - Irlanda	6
MX - Messico	6
TH - Thailandia	5
AT - Austria	4
SC - Seychelles	4
AR - Argentina	3
BG - Bulgaria	3
CI - Costa d'Avorio	3
ID - Indonesia	3
JO - Giordania	3
CH - Svizzera	2
IQ - Iraq	2
NG - Nigeria	2
PH - Filippine	2
PK - Pakistan	2
PL - Polonia	2
SI - Slovenia	2
VE - Venezuela	2
AU - Australia	1
BB - Barbados	1
BE - Belgio	1
CL - Cile	1
CR - Costa Rica	1
CW - ???statistics.table.value.countryCode.CW???	1
EG - Egitto	1
ET - Etiopia	1
HN - Honduras	1
JM - Giamaica	1
LT - Lituania	1
MA - Marocco	1
MD - Moldavia	1
MY - Malesia	1
OM - Oman	1
RU - Federazione Russa	1
SA - Arabia Saudita	1
SN - Senegal	1
TG - Togo	1
TR - Turchia	1
TT - Trinidad e Tobago	1
UA - Ucraina	1
ZA - Sudafrica	1
Totale	1.076

Nome	#
Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia	226
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents	217
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells	186
Emergence and Cytogenetic Clonal Evolution of Chromosome 7 Abnormalities in Myeloid Malignancies: Investigating the Role of Telomere Dysfunction	158
Release of IFNg by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells	139
Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia	121
IDH1/2 Mutations Are Maintained in a Subset of Patients with Acute Myeloid Leukemia in Complete Remission and Do Not Correlate with Residual Disease	54
Totale	1.101

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	20	0	0	0	3	3	2	0	3	0	2	4	3
2022/2023	72	2	4	2	8	14	10	1	4	13	6	4	4
2023/2024	44	3	1	8	9	4	12	2	2	0	1	2	0
2024/2025	175	6	16	10	8	7	4	12	8	3	25	38	38
2025/2026	629	61	83	46	50	31	21	46	31	147	55	30	28
2026/2027	116	19	25	34	38	0	0	0	0	0	0	0	0
Totale													1.101

CRIS Current Research Information System